HOME QUICK SEARCH AUTHORS KEYWORDS HELP BUGS

Fred Wood

31 papers; 31 titles; 16 coauthors.

Back to authors

Conference × Year × Title × Co-authors Extras Pages
PharmaSUG 2020 Trial Sets in Human Clinical Trials source 13
PharmaSUG 2019 Pacemaker Guy: De-Mystifying a Business Use Case for SDTM Standard and Medical Device Domains Carey G. Smoak,
Donna Sattler		 source 10
PharmaSUG 2019 What-s New in the SDTMIG v3.3 and the SDTM v1.7 source 13
PHUSE EU 2017 Considerations and Conventions in the Submission of the SDTM Tumor and Response Domain Jerry Salyers source
presentation source		 7
PharmaSUG 2017 Considerations and Conventions in the Submission of the SDTMIG Tumor and Response Domains Jerry Salyers source 7
PharmaSUG 2017 Considerations in Submitting Standardized Electronic Data Under the Animal Rule: The Use of Domains in the SDTMIG and the SENDIG source 7
PharmaSUG 2016 Considerations and Conventions within the Therapeutic Area User Guides (TAUGs) Jerry Salyers,
Kristin Kelly		 source 8
PharmaSUG 2016 SDTM Trial Summary Domain: Putting Together the TS Puzzle Kristin Kelly,
Jerry Salyers		 source 13
PharmaSUG 2016 The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data source 10
PharmaSUG 2015 Considerations in Submitting Non-Standard Variables: Supplemental Qualifiers, Findings About, or a Custom Findings Domain Jerry Salyers,
Richard Lewis		 source 6
PharmaSUG 2015 SDTM TE, TA, and SE Domains: Demystifying the Development of SE Kristin Kelly,
Jerry Salyers		 source 6
PharmaSUG 2015 What to Expect in SDTMIG v3.3 source 10
PharmaSUG 2014 Considerations in Creating SDTM Trial Design Datasets Jerry Salyers,
Richard Lewis,
Kimberly Minkalis		 source 9
PharmaSUG 2014 Considerations in the Submission of Exposure Data in SDTM-Based Datasets Jerry Salyers,
Richard Lewis,
Kristin Kelly		 source 6
PharmaSUG 2014 Data Standards Development for Therapeutic Areas: A Focus on SDTM-Based Datasets Diane Wold,
Rhonda Facile,
Wayne Kubick		 source 10
PharmaSUG 2013 Considerations in Data Modeling when Creating Supplemental Qualifiers Datasets in SDTM-Based Submissions source 12
PharmaSUG 2013 Considerations in the Use of Timing Variables in Submitting SDTM-Compliant Datasets Jerry Salyers,
Richard Lewis		 source 6
PharmaSUG 2013 Data Standards Will Be Required: Challenges for Medical Device Submissions Carey G. Smoak,
Kit Howard,
Rhonda Facile		 source 5
PharmaSUG 2012 Considerations in the Submission of Exposure Data in an SDTM-Compliant Format Jerry Salyers,
Richard Lewis		 source 4
PharmaSUG 2012 Considerations in the Submission of Pharmacokinetics (PK) Data in an SDTM-Compliant Format Peter Schaefer,
Richard Lewis		 source 8
PharmaSUG 2012 Seven New SDTM Domains for Medical Devices Carey G. Smoak,
Rhonda Facile,
Kit Howard		 source 4
PharmaSUG 2011 Creating SDTM Datasets from Legacy Data source 6
PharmaSUG 2011 The Standard for the Exchange of Nonclinical Data (SEND): History and Basics Lou Ann Kramer source 9
PharmaSUG 2011 Trials and Tribulations of SDTM Trial Design Mary Lenzen source 5
PharmaSUG 2010 Checking for SDTM Compliance: The Need for Human Involvement Adrienne Boyance 8
WUSS 2009 The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics source 9
PharmaSUG 2009 Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process 6
PharmaSUG 2008 The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics 8
PharmaSUG 2007 Evolution and Implementation of the CDISC Study Data Tabulation Model (SDTM) PharmaSUG Annual Meeting,
Tom Guinter		 47
PharmaSUG 2007 Evolution and Implementation of the CDISC Study Data Tabulation Model (SDTM) Tom Guinter 7
PharmaSUG 2006 Evolution and Implementation of the CDISC Study Data Tabulation Model (SDTM) Tom Guinter 6

Back to authors